Skip to main content
. 2017 Dec 19;9(2):2384–2394. doi: 10.18632/oncotarget.23415

Figure 6. ABC294640 inhibits C33A tumor growth in nude mice, sensitized by co-administration of GDC-0199.

Figure 6

C33A tumor-bearing mice were administrated withABC294640 (20 mg/kg, daily, p.o., for 21 days) and/or GDC-0199 (25 mg/kg, daily, i.p., for 21 days); estimated tumor volume (A) and mice body weight (deducting tumor weight, (C) were recorded weekly for total six weeks. At the end of experiment (week-7), tumors of the each group were isolated and weighted (B). Data were shown as mean (n=10) ± standard deviation (SD). *p<0.05 vs. “Vehicle” (0.375% Polysorbate-80) treatment. #p<0.05 vs. ABC294640 only treatment.